Neu Health is a pioneering startup that leverages advanced digital technologies to improve healthcare outcomes, particularly for individuals living with diseases and dementia. The company operates in the digital health market, focusing on providing innovative solutions for clinicians, caregivers, and patients. Neu Health's primary offering is a patient-centric, app-based platform that enables remote monitoring of disease progression. This platform requires minimal patient input—just seven minutes—to gather essential data.

The company builds on a decade of research and clinical validation conducted by neurologists, neuroscientists, and data scientists from the University of Oxford. Their technology has been successfully trialed and validated in over 1,500 participants, with findings published in international, peer-reviewed journals. This strong foundation in research ensures that Neu Health's solutions are both effective and reliable.

Neu Health's business model revolves around providing subscription-based services to healthcare providers and patients. The company generates revenue by offering its app and associated services, which include artificial intelligence (AI) and analytics tools that accurately measure disease progression and predict significant clinical outcomes up to 18 months in advance. This predictive capability allows for better medication management and informed, adaptive clinical decision-making.

The platform also offers remote clinician-guided management, optimizing access to clinical care and providing reassurance and education for patients and caregivers between clinical visits. By enabling patients to live independently and stay at home longer, Neu Health helps reduce the need for higher acuity care, ultimately lowering healthcare costs and improving quality of life.

Keywords: digital health, disease monitoring, dementia care, AI analytics, remote management, clinical validation, patient-centric, Oxford research, healthcare innovation, subscription service.